Roivant Sciences (ROIV, $11.39) was one of top quarterly gainers, jumping +1 to $11.39 per share. A.I.dvisor analyzed 912 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.